Evidence map›Paper›PMID 11958588›Full record

ReviewJournal of clinical immunology2002

CD28 function: a balance of costimulatory and regulatory signals.

Hélène Bour-Jordan, Jeffrey A Blueston

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of clinical immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hélène Bour-JordanUCSF Diabetes Center, University of California, San Francisco 94143, USA.
Jeffrey A Blueston
University of California, San Francisco · US

Funding

B7/CD28 MEDIATED COSTIMULATION IN THE PATHOLOGY OF R EAER01NS034819 · NINDS · NORTHWESTERN UNIVERSITY · PI MILLER, STEPHEN D · 1996 to 2003
$1.4M
MECHANISMS OF T CELL TOLERANCE IN CD28-DEFICIENT MICEP01AI035294 · NIAID · UNIVERSITY OF CHICAGO · PI BLUESTONE, JEFFREY A · 1993 to 2000
$750k
NIAID NIH HHS P01 AI 35294NINDS NIH HHS R01 NS34819
6 · The paper itself

Abstract

Both the recognition of MHC/antigen complex by the T-cell receptor and engagement of costimulatory molecules are necessary for efficient T-cell activation. CD28 has been widely recognized as the major costimulation pathway for naive T-cell activation, and the CD28/B7 pathway plays a central role in immune responses against pathogens, autoimmune diseases, and graft rejection. In this review, we will summarize evidence that CD28 is also prominent in the regulation of immune responses and the maintenance of peripheral tolerance. Indeed, CD28 engagement increases the expression of the down-modulatory molecule CTLA-4, induces the differentiation of Th2 cells that have a protective function in autoimmunity, and has an obligatory role in the homeostasis of regulatory T cells. Therefore, CD28/B7 interactions induce a balance of costimulatory and regulatory signals that have opposite outcomes on immune responses. This new perspective on CD28 function suggests that caution should be taken in the development of immunotherapies targeting costimulatory pathways.

Indexed as

ImmunoconjugatesAbataceptAnimalsAntigens, CDAntigens, DifferentiationB7-1 AntigenB7-2 AntigenCD28 AntigensCell DifferentiationCTLA-4 AntigenHumansLymphocyte ActivationMembrane GlycoproteinsMiceModels, ImmunologicalSignal TransductionAbataceptAntigens, CDAntigens, DifferentiationB7-1 AntigenB7-2 AntigenCD28 AntigensCD86 protein, humanCd86 protein, mouseCTLA-4 AntigenCTLA4 protein, humanCtla4 protein, mouseImmunoconjugatesMembrane Glycoproteins

Identifiers

PMID11958588
OpenAlexW1486790809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.